Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Alzheimers Res Ther ; 10(1): 20, 2018 02 16.
Artículo en Inglés | MEDLINE | ID: mdl-29452606

RESUMEN

CORRECTION: The correct title of the article [1] should be "Integrating multiple data sources (MUDS) for meta-analysis to improve patient-centered outcomes research: a protocol". The article is a protocol for a methodological study, not a systematic review.

3.
Syst Rev ; 4: 143, 2015 11 02.
Artículo en Inglés | MEDLINE | ID: mdl-26525044

RESUMEN

BACKGROUND: Systematic reviews should provide trustworthy guidance to decision-makers, but their credibility is challenged by the selective reporting of trial results and outcomes. Some trials are not published, and even among clinical trials that are published partially (e.g., as conference abstracts), many are never published in full. Although there are many potential sources of published and unpublished data for systematic reviews, there are no established methods for choosing among multiple reports or data sources about the same trial. METHODS: We will conduct systematic reviews of the effectiveness and safety of two interventions following the Institute of Medicine (IOM) guidelines: (1) gabapentin for neuropathic pain and (2) quetiapine for bipolar depression. For the review of gabapentin, we will include adult participants with neuropathic pain who do not require ventilator support. For the review of quetiapine, we will include adult participants with acute bipolar depression (excluding mixed or rapid cycling episodes). We will compare these drugs (used alone or in combination with other interventions) with placebo or with the same intervention alone; direct comparisons with other medications will be excluded. For each review, we will conduct highly sensitive electronic searches, and the results of the searches will be assessed by two independent reviewers. Outcomes, study characteristics, and risk of bias ratings will be extracted from multiple reports by two individuals working independently, stored in a publicly available database (Systematic Review Data Repository) and analyzed using commonly available statistical software. In each review, we will conduct a series of meta-analyses using data from different sources to determine how the results are affected by the inclusion of data from multiple published sources (e.g., journal articles and conference abstracts) as well as unpublished aggregate data (e.g., "clinical study reports") and individual participant data (IPD). We will identify patient-centered outcomes in each report and identify differences in the reporting of these outcomes across sources. SYSTEMATIC REVIEW REGISTRATION: CRD42015014037 , CRD42015014038.


Asunto(s)
Metaanálisis como Asunto , Evaluación de Resultado en la Atención de Salud/estadística & datos numéricos , Atención Dirigida al Paciente/estadística & datos numéricos , Proyectos de Investigación , Aminas/uso terapéutico , Analgésicos/uso terapéutico , Antipsicóticos , Trastorno Bipolar/tratamiento farmacológico , Ácidos Ciclohexanocarboxílicos/uso terapéutico , Interpretación Estadística de Datos , Gabapentina , Humanos , Neuralgia/tratamiento farmacológico , Fumarato de Quetiapina/uso terapéutico , Sesgo de Selección , Revisiones Sistemáticas como Asunto , Ácido gamma-Aminobutírico/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA